Countries affected
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData's latest Coronavirus Influencers…
Covid-19
Coronavirus
-
Global confirmed cases114,790,750
-
Global deaths2,547,398
-
Global death rate2.22%
-
Global recoveries75,617,698
-
Global recovery rate65.87%
-
Global confirmed cases114,790,750
-
Global deaths2,547,398
-
Global death rate2.22%
-
Global recoveries75,617,698
-
Global recovery rate65.87%
Coronavirus COVID-19 outbreakLatest news, information and updates
As the coronavirus spreads globally we track the confirmed cases, deaths, recoveries through this microsite, dedicated to Covid-19 updates. The microsite also provides insights into the international spread and social media reaction, alongside a coronavirus FAQ and all the latest news and information concerning the outbreak.
What you need to know
Suspected Cases
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the updates…
Social media tracker
Coronavirus Social Media Dashboard Pharmaceutical companies are in the spotlight as they race to develop…
Frequently asked questions
Answers to some of the most popular FAQs on coronavirus outbreak and COVID-19
Side-by-side comparison
Total cases vs total recovered patients vs total deaths.
Side-by-side comparison
COVID-19 is a global pandemic, with China accounting for a small share of cases
Coronavirus Blog
View MoreLatest on Coronavirus
View More
Merck to support manufacturing of Johnson & Johnson’s Covid-19 vaccine
Merck (MSD) has signed an agreement with Janssen Pharmaceuticals (JPI), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to support the manufacturing and…
ObvioHealth and RedHill to begin remote Covid-19 therapy trial
ObvioHealth is set to initiate a Phase II/III study of RedHill Biopharma’s RHB-107 (upamostat) in the US for Covid-19 treatment. ObvioHealth will use its clinical…
NIH pauses Covid-19 convalescent plasma trial
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as…
Cerecor’s antibody reduces respiratory failure in Covid-19 ARDS trial
Cerecor has reported that final efficacy data from Phase II trial of human anti-LIGHT (TNFSF14) monoclonal antibody, CERC-002, in hospitalised patients with Covid-19 linked pneumonia…
Hackers reportedly target Indian Covid-19 vaccine makers Serum Institute, Bharat Biotech
A Chinese hacking group has reportedly targeted the IT systems of two Indian Covid-19 vaccine makers, the Serum Institute of India (SII) and Bharat Biotech,…
Business optimism remains unchanged in February: Poll
Global Covid-19 vaccination drives have renewed hopes for recovery, but businesses remain cautious over outlook. Verdict has been conducting a poll to study the change…